Coppe Laboratories’ Lyme Testing Includes European Strains of Borrelia

Borrelia burgdorferi and Borrelia mayonii are the primary bacteria that cause Lyme Disease in the United States. Two other strains, Borrelia afzelii and Borrelia garinii, are the primary causes of Lyme disease in Europe and Asia. In a recent “Hot Topic” from the Mayo Clinic’s Dr. Elli Theel, a recommendation of using European immunoblots was recommended for individuals traveling outside the United States.  Wisconsin-based Coppe Laboratories is the only commercial reference laboratory in the U.S. that currently uses European immunoblots to detect multiple genospecies of Borrelia including B. burgdorferi, B. afzelii, B. garinii, and B. miyamotoi. Testing is recommended 4-6 weeks after a tick bite.

About Coppe Laboratories

Coppe Laboratories is a contract research organization and a CLIA-certified reference laboratory in Waukesha, Wisconsin (USA) specializing in research and diagnostics for emerging viral diseases. Since its founding in 2012, Coppe has delivered unparalleled clinical lab service to academic and children’s hospitals, integrative medicine specialists, and clinical research centers nationwide. Our scientists provide custom contract research services, designing essential experiments and providing preliminary data in support of biotech and pharmaceutical industries worldwide.

View all posts by Coppe Laboratories